• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not?

作者信息

Dal Moro Fabrizio

机构信息

Department of Surgery, Oncology and Gastroenterology, Urology, University of Padova, Via Giustiniani 2, 35128, Padua, Italy.

Urologic Clinic, "Santa Maria della Misericordia" Hospital, University of Udine, Udine, Italy.

出版信息

World J Urol. 2019 Dec;37(12):2803. doi: 10.1007/s00345-018-2533-y. Epub 2018 Oct 23.

DOI:10.1007/s00345-018-2533-y
PMID:30353293
Abstract
摘要

相似文献

1
A specific scoring system able to predict the efficacy of the therapy for bladder cancer: why not?一种能够预测膀胱癌治疗疗效的特定评分系统：为何不呢？
World J Urol. 2019 Dec;37(12):2803. doi: 10.1007/s00345-018-2533-y. Epub 2018 Oct 23.
2
Novel nomograms to predict recurrence and progression in primary non-muscle-invasive bladder cancer: validation of predictive efficacy in comparison with European Organization of Research and Treatment of Cancer scoring system.新型列线图预测原发性非肌肉浸润性膀胱癌的复发和进展：与欧洲癌症研究与治疗组织评分系统相比预测效能的验证。
World J Urol. 2019 Sep;37(9):1867-1877. doi: 10.1007/s00345-018-2581-3. Epub 2018 Dec 10.
3
External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guérin.欧洲癌症研究与治疗组织及西班牙肿瘤治疗泌尿学俱乐部评分模型的外部验证，用于预测接受卡介苗治疗的日本非肌层浸润性膀胱癌患者的复发和进展情况。
Int J Urol. 2014 Dec;21(12):1201-7. doi: 10.1111/iju.12572. Epub 2014 Jul 30.
4
Scoring Systems Used to Predict Bladder Dysfunction After Laparoscopic Rectal Cancer Surgery.用于预测腹腔镜直肠癌手术后膀胱功能障碍的评分系统。
World J Surg. 2016 Dec;40(12):3044-3051. doi: 10.1007/s00268-016-3636-5.
5
Stratifying patients with haematuria into high or low risk groups for bladder cancer: a novel clinical scoring system.将血尿患者分层为膀胱癌高风险或低风险组：一种新型临床评分系统。
Asian Pac J Cancer Prev. 2013;14(11):6327-30. doi: 10.7314/apjcp.2013.14.11.6327.
6
Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer.膀胱癌卡介苗免疫治疗的最新进展。
Immunotherapy. 2010 Jul;2(4):551-60. doi: 10.2217/imt.10.32.
7
[Comprehensive therapy of bladder preservation for muscle invasive bladder cancer].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jan 28;43(1):82-89. doi: 10.11817/j.issn.1672-7347.2018.01.013.
8
[Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].[欧洲癌症研究与治疗组织评分系统对非肌层浸润性膀胱癌经尿道切除术后即刻膀胱内灌注吡柔比星预测的价值]
Zhonghua Zhong Liu Za Zhi. 2018 Apr 23;40(4):308-312. doi: 10.3760/cma.j.issn.0253-3766.2018.04.014.
9
Urinary cytology in bladder cancer: why is it still relevant?膀胱癌中的尿液细胞学检查：为何它仍具有重要意义？
Urologia. 2015 Oct-Dec;82(4):203-5. doi: 10.5301/uro.5000129. Epub 2015 Jul 15.
10
A novel molecular grading model: combination of Ki67 and VEGF in predicting tumor recurrence and progression in non-invasive urothelial bladder cancer.一种新型分子分级模型：Ki67与VEGF联合用于预测非侵袭性膀胱尿路上皮癌的肿瘤复发和进展
Asian Pac J Cancer Prev. 2012;13(5):2229-34. doi: 10.7314/apjcp.2012.13.5.2229.

本文引用的文献

1
Molecular markers in bladder cancer.膀胱癌的分子标志物。
World J Urol. 2019 Jan;37(1):31-40. doi: 10.1007/s00345-018-2503-4. Epub 2018 Sep 26.
2
Effect of hypertension on outcomes of high-risk patients after BCG-treated bladder cancer: a single-institution long follow-up cohort study.高血压对卡介苗治疗的膀胱癌高危患者预后的影响：一项单机构长期随访队列研究。
Medicine (Baltimore). 2015 Mar;94(9):e589. doi: 10.1097/MD.0000000000000589.
3
Urinary markers in the everyday diagnosis of bladder cancer.膀胱癌日常诊断中的尿液标志物
Urologia. 2013 Sep-Dec;80(4):265-75. doi: 10.5301/urologia.5000041. Epub 2013 Nov 29.
4
Does age really matter in the choice of treatment for bladder cancer?年龄在膀胱癌治疗选择中真的重要吗？
Br J Cancer. 2013 Jun 11;108(11):2415-6. doi: 10.1038/bjc.2013.239. Epub 2013 May 14.